Evaxion Q2 FY26 net loss narrows to USD 3.7 million; revenue posts no revenue

PUBT · 3d ago
Evaxion Q2 FY26 net loss narrows to USD 3.7 million; revenue posts no revenue
  • Evaxion reported Q2 2026 net loss of USD 3.7 million, improving from a USD 4.8 million loss in Q2 2025.
  • Operating loss narrowed to USD 3.85 million from USD 4.34 million a year earlier; finance expense fell to USD 0.1 million from USD 0.7 million.
  • R&D spending rose to USD 2.33 million from USD 2.17 million, while G&A expense dropped to USD 1.51 million from USD 2.21 million.
  • Cash slid to USD 14 million at June 30 from USD 18.4 million at March 31; runway unchanged into H2 2027.
  • Pipeline update flagged EVX-01 three-year melanoma data at ESMO 2026; EVX-04 filing expected before year-end; EVX-05 added.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evaxion A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608200730PRIMZONEFULLFEED1001258477) on August 20, 2026, and is solely responsible for the information contained therein.